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INTRODUCTION
The gastric mucosa recognizes a variety of chemi-
cal characteristics of food from simple, such as os-
motic pressure and pH, to complex, such as mole-
cules of macronutrients. These chemical character-
istics of a meal signal quality as well as quantity.
This information alters gastric secretomotor func-
tion by activating specific nervous and endocrine
pathways and related mechanisms at the very be-
ginning of digestive process (1, 2). Among other
nutrients, amino acids and short hydrophobic pep-
tides are known as the most active stimuli inducing
gastrin release and acid secretion in the stomach
(3, 4). The origin of free amino acids and short pep-
tides in the gastric lumen is straightforward. In-
gested dietary protein and peptides are cleaved by
activated pepsin preferentially on the COOH-termi-
nal sides of aromatic amino acids including L-Phe,
L-Trp and L-Tyr (5). Thus, at the beginning of pro-
tein digestion some short peptides and amino acids
are released before exiting the stomach. The only
amino acid which is regularly ingested in a free
form is glutaminic acid or its ionic form glutamate,
well recognized for its characteristic umami taste.
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FREE GLUTAMATE IN GASTRIC LUMEN
L-Glutamate (Glu) in a free form is found at
marked concentrations both in animal and plant
foodstuffs such as green tea, seaweed, mushrooms,
potato, Chinese cabbage, soybean, sardines, shrimps,
and milk (6). High concentrations of Glu are found
in ripe tomatoes (140 mg/100 g) and in Parmesan
cheese (1200 mg/100 g). As a food additive, Glu is
generally used as a sodium salt (monosodium glu-
tamate, MSG). Average consumption for Europeans
is 0.3-0.5 g/day individually ; in Asian countries the
intake of added Glu is estimated to 1.2-1.7 g/day
(7). An important potential application of free dietary
Glu is to use it in supplements of hospital meals and
diets for enteral nutrition. Glu is a major oxidative
fuel and an important substrate for the synthesis of
the other amino acids, glutathione, and protein in
the intestine (8, 9) and is often applied to augment
gut function. Addition of 3 g of Glu to daily hospi-
tal meals of patients with chronic atrophic gastritis
for 24 days improved appetite, gastric acid secre-
tion and secretion of gastrin (10). In parallel, this
treatment reduced dyspepsia, and lipid peroxidation
and caused an increase of body mass (11). Enteral
Glu brought a survival advantage to hematological
and oncological patients (12). In elderly patients,
MSG supplementation of food caused an increase of
food intake and improved nutritional status (13).
Furthermore, moderate increase of luminal Glu may
offer a therapeutic approach to stimulate gastroduo-
denal contractile activity and to reduce feeding in-
tolerance in premature infants (14, 15).
GASTRIC MUCOSA SENSING OF GLUTA-
MATE
There is little doubt that the gastrointestinal (GI)
mucosa is the main site for regulatory action of en-
teral Glu, because under normal circumstances of di-
gestion, almost all ingested Glu is extensively me-
tabolized in the mucosal cells and does not appear
in the portal circulation (8). Several sites of interac-
tion of dietary amino acids are described at the api-
cal membranes of gastric mucosal cell, including cal-
cium sensing receptors (CaSRs) (1, 4), metabotropic
glutamate receptors type 1 (mGluR1) (16), T1R1/
T1R3 peptides (17), and amino acid transporters
(18). CaSRs are expressed in gastric acid-secreting
parietal cells and pepsinogen-secreting chief cells
(19, 20), as well as in surface mucus-secreting cells
(21) and gastrin-secreting G-cells in the antrum
(22). These receptors activated by divalent cations
are also sensitized by several kinds of amino acids,
i.e. aromatic, polar and acidic ones, but aromatic
amino acids are the most potent among them (1). A
specific taste receptor for Glu (mGluR1) was initially
revealed immunohistochemically at the apical mem-
brane of chief cells in the lower region of the fun-
dic glands in the rat stomach (16). Quite recently,
Gi-protein coupling mGluR subtypes were also iden-
tified in the somatostatin-secreting D-cell fraction
of the gastric mucosa (23). The heterodimer T1r1/
T1r3 is known as an umami taste receptor in the
taste buds on the surface of the tongue. These di-
mer components were identified by PCR in the an-
tral stomach tissues of mice (17). However, the
precise localization of the T1r1 and T1r3 heterodi-
mer in stomach mucosa is not yet been reported.
Finally, the excitatory amino acid transporter 1
(GLAST) has been labeled along the luminal sur-
face both mucus neck cells and parietal cell of the
mouse stomach (18).
DIETARY GLUTAMATE AND DIGESTIVE
FUNCTIONS
There is substantial evidence that dietary glu-
tamate, identified by gustatory and gut receptors,
modulates physiological functions in the GI tract.
Oral uptake of MSG stimulates cephalic phase exo-
crine secretions of saliva, bile and pancreatic juice
(24-26), in parallel with secretion of insulin (27).
In the 1990s, a role of dietary Glu in control of the
gastric secretion was first investigated in series of
studies in dogs. Ingestion of 2.8 g of MSG elevated
and prolonged secretion of gastric juice induced by
either meaty food or injection of pentagastrin (28).
However, aqueous MSG solution did not affect these
basal levels nor secretion caused by sham feeding
in dogs (29). Further, in healthy human volunteers,
enrichment of liquid diets with 0.5% MSG (w/v) en-
hanced the gastric empting rate. However, intuba-
tion of aqueous MSG solution alone did not affect
stomach motility as compared to water. Physiologi-
cal functions of MSG in the stomach are varied de-
pending on the co-existing macronutrients, i.e. pro-
tein, carbohydrate, fat and so on. For example, gas-
tric empting rate of liquid diet is enhanced when
MSG is co-applied with protein diet but does not in
the case of protein free one. This permissive effect is
coupled with recognition of individual macronutrient
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intake by the brain and control of consequent diges-
tion in the intestine (30).
Glu-sensing systems in the stomach are linked to
activation of the vagal afferents that transmit food
signals to the brain. Short latency impulse dis-
charges of both afferent and efferent fibers of the
gastric branches of the vagus nerve were stimulated
specifically by luminally applied Glu but not other
natural amino-acids (2, 31). In contrast, hepatic af-
ferents respond to all amino acids delivered into
the portal vein (32). Luminal Glu activates the va-
gal afferents in the gastric submucosa through the
paracrine cascade, led by nitric oxide and followed
by serotonin (5-HT), which in turn interacts with 5-
HT3 receptors on afferent fibers (2, 33).
LUMINAL MSG AND GASTRIC SECRE-
TION
As described above, luminally applied Glu modu-
lates gastric functions via local mechanisms, by in-
teracting directly with secretory cells in the gastric
glands, or through neuroendocrine pathways. We
have recently studied the role of enteral MSG in
vago-vagal reflex control of gastric secretion. In this
research we used the dog model with a surgically
split stomach, known as a small gastric pouch, as
originally described by Pavlov (34). The small gas-
tric pouch was prepared from tissues of the fundus
and the upper corpus preserving vagal branches. It
was fully separated from the main stomach, so that
solutions applied to the main stomach did not in-
teract with mucosa of the pouch. Aqueous MSG so-
lutions intubated through a fistula directly into the
main stomach at concentrations of 10-100 mM did
not affect basal secretion from the small Pavlov gas-
tric pouch. In contrast, a small amount (20 mL) of
liquid diet (Elental), containing 17 amino acids as
the protein source (excluding Glu), or a carbohy-
drate - rich diet (based on decstrin) without amino
acids (both manufactured by Ajinomoto Co., Inc,
Tokyo, Japan) stimulated moderate acid and fluid
output from the pouch. Supplementation of Elental
with 10-100 mM MSG (equimolar NaCl used as
control) enhanced secretion of acid and fluid in a
concentration-dependent fashion. Furthermore, ad-
dition of MSG induced pepsinogen production in the
pouch, which did not occur when the Elental liq-
uid diet was infused alone. However, MSG had no
enhancing effect on the secretory response to the
carbohydrate-rich diet (Fig. 1). The stimulative ef-
fect of MSG in the Elental liquid diet was totally
Fig. 1 Supplementation with 100 mM monosodium L-glutamate (MSG) enhanced gastric secretion induced by a high-caloric amino
acid-rich diet, but it did not affect secretion induced by a carbohydrate-rich amino acid- free diet in Pavlov pouch dogs. A) Secretion
of acid, pepsinogen and fluid in the small gastric pouch stimulated with an amino acid-rich diet (see details in the text). B) Secretion
in the small gastric pouch induced by a carbohydrate-rich, amino acid- free diet. Both diets were infused through a fistula into the
main stomach ; secretions were measured in the washes from the Pavlov pouch. Data are expressed as meansSEM. Solutions were
intubated into the main stomach after a 45-min stabilization period ; bolus infusions are marked with arrows. Paired comparisons
were made with Student’s t test ; * : p0.05, ** : p0.01 ; n=9 in each group.
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suppressed after intra-gastric infusion of a local an-
esthetic, lidocaine (5%), which blocked submucosal
afferent responses. Recently it has been shown that
antagonism of 5-HT3 receptors with granisetron se-
lectively attenuates Glu-specific impulse discharge
in gastric branches of the vagus nerve associated
with stimulation of mucosal mGluR1 (2). In our
study, granisetron (20 μg/kg, i.v.) did not affect ba-
sal secretions from the Pavlov gastric pouch but it
did attenuate increases in secretion when MSG was
co-applied with Elental. Blockage of 5-HT3 recep-
tors totally abolished the MSG-induced increase
of pepsinogen secretion and partially reduced the
enhancement of acid and fluid output, indicating
that the effect of dietary MSG on gastric secretion
is partially mediated by 5-HT3 receptors.
CONCLUSIONS
The regulatory role of umami substances in the
process of digestion is not restricted to cephalic
phase secretion of digestive juices and insulin which
depend upon excitation of taste receptors in the oral
cavity. Being the only amino-acid regularly ingested
in a free form, Glu in the stomach induces physi-
ological effects. It directly interacts with receptors
on both exocrine and endocrine cell in the gastric
mucosa, for example chief cells and probably also
D-cells, and it stimulates nervous pathways. At doses
not exceeding its typical concentrations in food, itra-
gastrically applied Glu activates vagal afferent fibers
in the stomach through production and release of
nitric oxide and consequently serotonin in mucosal
cells. We have shown that stimulation of the gastric
afferent response by direct infusion of Glu into the
stomach enhances gastric phase secretion, espe-
cially secretion of pepsinogen ; and that this effect
partially depends on activation of 5-HT3 receptors.
In several experimental models it was demonstrated
that aqueous solutions of MSG do not affect secre-
tion or motility in the stomach. Instead, MSG be-
comes a moderate activator of gastric functions
when it is co-applied with other nutrients. Impor-
tantly, Glu selectively interacts with nutrients, en-
hancing the effects of protein- or amino acid-rich
diets but does not have this effect with a protein-
free carbohydrate diet. New data concerning the ex-
pression of Glu receptors on D-cells allow us to
speculate that nervous system effect induced by
dietary MSG on gastric secretion is amplified by si-
multaneous MSG-induced reduction of somatostatin
release (23). Finally, the success of the enteral feed-
ing of patients may depend on the secretory state
of the stomach (35). Our studies in combination
with others previously published show that free
Glu supplementation of elementary liquid diets
should improve gastric secretory capacity and en-
hance motility. MSG supplement of liquid diets
should be considered for patients with GI compli-
cations.
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